PPT-Treatment Options for Opioid Use Disorder

William J Lorman JD PhD MSN PMHNPBC CARNAP V P amp Chief Clinical Officer Livengrin Foundation Inc Asst Clinical Professor Doctoral Nursing Dept Drexel University wlormanlivengrinorg. John e lopes . j. r. .. , . dhs. c. , pa-c. A. ssociate Professor, . Physician Assistant Program. Central Michigan University. and . Project Director. Medication-assisted Treatment Waiver Training Initiative. IN ARMS September 26, 2016. Prepared by. Leslie . Hulvershorn. , MD. Medical Director,. . Division of Mental Health and . Addiction, FSSA. Leslie.Hulvershorn@fssa.IN.gov. Presented by. Dennis Ailes, MA. A . Roadmap for Care Providers. Davina Moss-King, Ph.D.. Positive Direction and Associates, Inc.. March 17, 2018. 1. Some Information Adapted from ACOG District II Presentation Opioid Use Disorder Bundle, 2018. Welcome. Thank you for joining us for our 1. st. AIM Opioid Webinar. Housekeeping:. Session is being recorded. Session will be posted under the opioid section of the AIM website: . https://safehealthcareforeverywoman.org/national-collaborative-on-maternal-oud/. Angeline Stanislaus, MD. Chief Medical director- adult services. Missouri . Dept. of Mental Health. How many people are dying each day?. 115. Overdoses. Missouri- Total number of opioid related death 2017. CA . Hub. and Spoke MAT . ECHO® Clinic. Faculty: Candy Stockton-Joreteg, MD, Larissa Mooney, MD, Gloria Miele, Ph.D., Thomas E. Freese, Ph.D.. Monday, December 3. rd. , 2018. This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government. And Clinical Implications. Surita Rao, M.B.B.S, M.D., FASAM. . Program Director, Psychiatry Residency Training Program. Associate Professor of Psychiatry. University of Connecticut School of Medicine. MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD) Opioid Use Disorder (OUD): A medical condition characterized by a problematic pattern of opioid use that causes clinically significant impairment or distress. (FORE), a private, national organizationfocused on contributing sustainable and scalable solutions to the opioid crisis, today announced that it is making$10million in grants toorganizations across th : . Addressing Fear and Discrimination (Part I). Sharon Morello RN, BSN . Opioid Epidemic and Substance Use Disorders. . Heroin use climbed then stabilized . See table 7.2 in the 2017 NSDUH detailed tables for additional information and the 2017 CDC Mortality Data.. A. gonist Treatment . f. or . R. acial and Ethnic Minorities. Jawad M. Husain, MD . 1,2. , Devin Cromartie MD, MPH . 3,4. , Emma . Fitzelle. -Jones, MPH . 5. , . Annelise . Brochier. , MPH . 6. ,. . This . project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.. TOGETHER, WE ARE UNITING TO HELP.. togetherarkansas.com. +. ARKANSAS HAS THE . 2ND HIGHEST. . OPIOID USE RATE IN THE NATION. . O. pioid use. disorder is affecting businesses . of every kind — . from small operations to large . Dr. Sonalika’s Eye Clinic provide the best Eye infection treatment, Conjunctivitis treatment in pune, Hadapsar, Amanora, Magarpatta, Mundhwa, Kharadi Rd, Viman Nagar, Wagholi, and Wadgaon Sheri